Here are what the editors at HealthDay consider to be the most important developments in Internal Medicine for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Rates of Postoperative Mortality High for Frail, […]
Read MoreHere are what the editors at HealthDay consider to be the most important developments in Critical Care for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Three Meds Equal as Second-Line Therapy for […]
Read MoreHere are what the editors at HealthDay consider to be the most important developments in Emergency Medicine for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Three Meds Equal as Second-Line Therapy for […]
Read MoreHere are what the editors at HealthDay consider to be the most important developments in Otolaryngology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Object-Related Aspiration Deaths Decreased Among Children WEDNESDAY, Nov. […]
Read MoreHere are what the editors at HealthDay consider to be the most important developments in Nephrology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. U.S. Life Expectancy Dropped Since 2014 for Working-Age […]
Read More
Here are what the editors at HealthDay consider to be the most important developments in Pathology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Antimicrobial Resistance Patterns Examined for Adult, Peds HAIs […]
Read MoreHere are what the editors at HealthDay consider to be the most important developments in Radiology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Fewer Interval Cancers Diagnosed With Supplemental MRI for […]
Read MoreHere are what the editors at HealthDay consider to be the most important developments in Anesthesiology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. U.S. Life Expectancy Dropped Since 2014 for Working-Age […]
Read MoreHere are what the editors at HealthDay consider to be the most important developments in Cosmetic Surgery for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. U.S. Life Expectancy Dropped Since 2014 for […]
Read MoreHere are what the editors at HealthDay consider to be the most important developments in Geriatrics for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Rates of Postoperative Mortality High for Frail, Very […]
Read MoreHere are what the editors at HealthDay consider to be the most important developments in Pain Management for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Cancer Patients Need More Info on Side […]
Read MoreHere are what the editors at HealthDay consider to be the most important developments in Pharmacy for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Three Meds Equal as Second-Line Therapy for Status […]
Read More
Further follow-up needed to assess benefit of PSA screening in male BRCA1 mutation carriers
Read More
Odds of incident eating disorder diagnosis up with use of diet pill, laxative for weight control
Read More
Frequent handwashing may reduce likelihood of novel strain introduction into the household
Read More
37 percent of patients experience radiation adverse effects they wished they had known more about
Read More
Age <65 years, female sex, high comorbidity burden independently linked to cost-related nonadherence
Read More
Antimicrobial nonsusceptibility less prevalent in pediatric than adult health care-associated infections
Read More
1968 to 2017 saw decrease in object-related aspiration deaths among adolescents and children
Read More
Exposure to most substances decreased, but significant increases seen in marijuana, nutmeg, and kratom
Read More
